109 related articles for article (PubMed ID: 336410)
1. Hepatic effects of oral hypoglycemic drugs.
Davidoff F
Fed Proc; 1977 Dec; 36(13):2724-7. PubMed ID: 336410
[No Abstract] [Full Text] [Related]
2. Oral hypoglycemic agents: the pharmacological basis of their clinical use.
Davidoff F
R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221
[No Abstract] [Full Text] [Related]
3. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
De Vries CP; van der Veen EA
Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414
[TBL] [Abstract][Full Text] [Related]
4. [Mode of action of oral antidiabetic drugs].
Frey H
Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1591-5. PubMed ID: 4588814
[No Abstract] [Full Text] [Related]
5. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
Losert W; Hoder A; Scholz C
Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
[No Abstract] [Full Text] [Related]
6. Clinical use of oral hypoglycemic agents.
Hagg SA
Am J Hosp Pharm; 1976 Sep; 33(9):943-7. PubMed ID: 790951
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral antidiabetic drugs on lipase activity in vitro.
Holmes JH; Sapeika N; Zwarenstein H
Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):667-70. PubMed ID: 1179037
[TBL] [Abstract][Full Text] [Related]
8. Effects of biguanides and sulfonylureas on insulin receptors in cultured cells.
Goldfine ID; Iwamoto Y; Pezzino V; Trischitta V; Purrello F; Vigneri R
Diabetes Care; 1984; 7 Suppl 1():54-8. PubMed ID: 6734405
[TBL] [Abstract][Full Text] [Related]
9. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
Fövényi J
Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
[No Abstract] [Full Text] [Related]
10. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
Harrigan RA; Nathan MS; Beattie P
Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk.
Uwaifo GI; Ratner RE
Am J Cardiol; 2007 Feb; 99(4A):51B-67B. PubMed ID: 17307058
[TBL] [Abstract][Full Text] [Related]
12. [Clinical pharmacology and rational therapeutic use of antidiabetic drugs].
Giraudo JR
Rev Fac Cien Med Univ Nac Cordoba; 1979; 37(1-4):28-33. PubMed ID: 556116
[No Abstract] [Full Text] [Related]
13. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
Lebedeva EA
Eksp Klin Farmakol; 1996; 59(5):40-2. PubMed ID: 9026209
[TBL] [Abstract][Full Text] [Related]
14. Assay of liver membrane insulin receptors in obese, hyperglycaemic (ob/ob) mice: stimulant effect of an oral antidiabetic sulphonylurea drug [proceedings].
Greenstein BD
Br J Pharmacol; 1979 May; 66(1):86P. PubMed ID: 454969
[No Abstract] [Full Text] [Related]
15. [The effects of blood glucose lowering biguanides on liver metabolism].
Söling HD
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():656-77. PubMed ID: 4906984
[No Abstract] [Full Text] [Related]
16. [Effects of some sulfonylurea derivatives on liver extracts cultivated in vitro. I. Morphology].
Conti G; Hadhazy C; Cappelli B; Spreca A; Gotzos V
Pharm Acta Helv; 1971 Aug; 46(8):497-507. PubMed ID: 5092968
[No Abstract] [Full Text] [Related]
17. Extrapancreatic effects of sulfonylurea drugs.
Kaku K; Inoue Y; Kaneko T
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S105-8. PubMed ID: 8529502
[TBL] [Abstract][Full Text] [Related]
18. [Oral hypoglycemic agents--overview].
Sakamoto N; Uno T
Nihon Rinsho; 1997 Nov; 55 Suppl():94-8. PubMed ID: 9434450
[No Abstract] [Full Text] [Related]
19. [The effect of oral hypoglycemic agents on the fatty acid composition of liver and depot lipids in rats].
Bernhard K; Spreng E
Z Klin Chem Klin Biochem; 1971 May; 9(3):242-4. PubMed ID: 5153836
[No Abstract] [Full Text] [Related]
20. [Study of the protective activity of glisolamide on experimental atherosclerosis in the rabbit].
Dalla Vedova R; Cadel S; D'Alò G
G Clin Med; 1979 Nov; 60(11):911-26. PubMed ID: 546672
[No Abstract] [Full Text] [Related]
[Next] [New Search]
